NO891835L - Prodrug-former av 2',3'-didehydro-2',3'-dideoksy-nukleosider. - Google Patents
Prodrug-former av 2',3'-didehydro-2',3'-dideoksy-nukleosider.Info
- Publication number
- NO891835L NO891835L NO89891835A NO891835A NO891835L NO 891835 L NO891835 L NO 891835L NO 89891835 A NO89891835 A NO 89891835A NO 891835 A NO891835 A NO 891835A NO 891835 L NO891835 L NO 891835L
- Authority
- NO
- Norway
- Prior art keywords
- didehydro
- prodrug forms
- dideoxy nucleosides
- dideoxy
- nucleosides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19080988A | 1988-05-06 | 1988-05-06 | |
| US33344989A | 1989-04-07 | 1989-04-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO891835D0 NO891835D0 (no) | 1989-05-03 |
| NO891835L true NO891835L (no) | 1989-11-07 |
Family
ID=26886473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89891835A NO891835L (no) | 1988-05-06 | 1989-05-03 | Prodrug-former av 2',3'-didehydro-2',3'-dideoksy-nukleosider. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0340778A3 (no) |
| JP (1) | JPH02152976A (no) |
| KR (1) | KR900018093A (no) |
| AU (1) | AU3407189A (no) |
| DK (1) | DK221789A (no) |
| FI (1) | FI892132A7 (no) |
| IL (1) | IL90171A0 (no) |
| NO (1) | NO891835L (no) |
| PT (1) | PT90475B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0355031A3 (de) * | 1988-08-17 | 1990-12-27 | MATTHES, Eckart, Dr. | Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel |
| DD293498A5 (de) * | 1989-07-20 | 1991-09-05 | Zi Fuer Molekularbiologie Der Adw,De | Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier |
| CA2079796A1 (en) * | 1990-04-04 | 1991-10-05 | Jo Klaveness | Nucleoside derivatives |
| US5627160A (en) * | 1993-05-25 | 1997-05-06 | Yale University | L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
| TW374087B (en) * | 1993-05-25 | 1999-11-11 | Univ Yale | L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents |
| US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
| EP2537851B1 (en) | 2010-02-15 | 2015-06-10 | Nissan Chemical Industries, Ltd. | Process for preparation of b-glycoside compounds |
| EP2537839B1 (en) * | 2010-02-15 | 2016-12-14 | Nissan Chemical Industries, Ltd. | B-dihydrofuran deriving compound, method for producing b-dihydrofuran deriving compound or b-tetrahydrofuran deriving compound, b -glycoside compound, method for producing b-glycoside compound, and method for producing 4'-ethynyl d4t and analogue compounds thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR960001372B1 (ko) * | 1986-09-24 | 1996-01-26 | 예일 유니버시티 | 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질 |
| US4904770A (en) * | 1988-03-24 | 1990-02-27 | Bristol-Myers Company | Production of 2',3'-dideoxy-2',3'-didehydronucleosides |
| EP0355031A3 (de) * | 1988-08-17 | 1990-12-27 | MATTHES, Eckart, Dr. | Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel |
| DE3900964A1 (de) * | 1989-01-14 | 1990-07-19 | Boehringer Mannheim Gmbh | Neue nukleoside, verfahren zu deren herstellung sowie arzneimittel, die diese verbindungen enthalten |
-
1989
- 1989-05-02 JP JP1112371A patent/JPH02152976A/ja active Pending
- 1989-05-03 IL IL90171A patent/IL90171A0/xx unknown
- 1989-05-03 FI FI892132A patent/FI892132A7/fi not_active IP Right Cessation
- 1989-05-03 NO NO89891835A patent/NO891835L/no unknown
- 1989-05-04 KR KR1019890006044A patent/KR900018093A/ko not_active Withdrawn
- 1989-05-05 EP EP19890108099 patent/EP0340778A3/en not_active Withdrawn
- 1989-05-05 DK DK221789A patent/DK221789A/da not_active Application Discontinuation
- 1989-05-05 AU AU34071/89A patent/AU3407189A/en not_active Abandoned
- 1989-05-05 PT PT90475A patent/PT90475B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL90171A0 (en) | 1989-12-15 |
| PT90475B (pt) | 1994-08-31 |
| AU3407189A (en) | 1989-11-09 |
| DK221789D0 (da) | 1989-05-05 |
| PT90475A (pt) | 1989-11-30 |
| NO891835D0 (no) | 1989-05-03 |
| DK221789A (da) | 1989-11-07 |
| EP0340778A2 (en) | 1989-11-08 |
| FI892132L (fi) | 1989-11-07 |
| KR900018093A (ko) | 1990-12-20 |
| EP0340778A3 (en) | 1990-11-22 |
| FI892132A7 (fi) | 1989-11-07 |
| JPH02152976A (ja) | 1990-06-12 |
| FI892132A0 (fi) | 1989-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO891208D0 (no) | Fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider. | |
| PT526253E (pt) | Analogos do nucleosido 1,3-oxatiolano | |
| NO883299L (no) | Epipodofyllotoksinglukosid-4'-fosfatderivater. | |
| ATE110271T1 (de) | 3'-azido-2',3'-dideoxyuridin anti-retrovirale zusammensetzung. | |
| DE68923387D1 (de) | 2',3'-Dideoxy-2',2'-difluornucleoside. | |
| FI880405A7 (fi) | Adenosin-5'-karboxamidderivat. | |
| NO890253D0 (no) | Dideoksydidehydrokarbocykliske nukleosider. | |
| DE3888530D1 (de) | 3'-Azido-2',3'-dideoxynucleosid-5'-phosphonate. | |
| DK630589D0 (da) | 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning | |
| NO891835L (no) | Prodrug-former av 2',3'-didehydro-2',3'-dideoksy-nukleosider. | |
| DE68914750D1 (de) | Therapeutische Nucleoside. | |
| NO882849D0 (no) | 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater. | |
| FI912513L (fi) | Syntes av nukleotid- och nukleosidderivat. | |
| NO910607D0 (no) | Fremgangsmaate for fremstilling av 3'-fluor-nukleosidanaloger. | |
| NO913459L (no) | Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider. | |
| NO913457L (no) | Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider. | |
| NO913456D0 (no) | Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider. | |
| NO913458D0 (no) | Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider. | |
| FI945699A0 (fi) | 2',3'-dideoksi-2',3'-didehydronukleosidien valmistus | |
| NO884264L (no) | 3'-azido-2',3'-dideoksyuridin-anti-retrovirus-blanding. | |
| FI945700L (fi) | 2',3'-dideoksi-2',3'-didehydronukleosidien valmistus | |
| FI945698L (fi) | 2',3'-dideoksi-2',3'-dehydronukleosidien valmistus | |
| ATE104675T1 (de) | Therapeutische nucleoside. |